To demonstrate the usefulness of KM-Express on biomarker discovery and functional validation, we examined several previously reported RNA biomarkers for breast cancer including the long non-coding RNA (lncRNA) LINC00472 (29), miR429 (30, 31) and VEGFR1 (FLT1) (32). This evidence concerns the gene FLT1 and breast cancer.